Cover image of the article: Effects of Hepatitis B Surface and Hepatitis B Core Antigens from Hepatitis B Virus Genotypes B and C on In Vitro Apoptosis

Image Credit:Hepat Mon

Effects of Hepatitis B Surface and Hepatitis B Core Antigens from Hepatitis B Virus Genotypes B and C on In Vitro Apoptosis

Authors

Shervin ShokouhiShervin Shokouhi ORCID1,*, Mohammad Rakhshan2, Latif Gachkar2, Elham Khalaj2, Sasan Sazgar2
1Assistant Professor of Infectious Diseases, Loghman Hakim Hospital, Kamali Street, South Karegar Avenue & Department of Infectious Diseases, Shaheed Beheshti University of Medical Sciences, shsh.50@gmail.com, Tehran, IR.Iran
2Department of Pathology, Shaheed Beheshti University of Medical Sciences, Tehran, IR.Iran
*Corresponding Author: Assistant Professor of Infectious Diseases, Loghman Hakim Hospital, Kamali Street, South Karegar Avenue & Department of Infectious Diseases, Shaheed Beheshti University of Medical Sciences, shsh.50@gmail.com, Tehran, IR.Iran. Fax: +98 21 55411717. Email: shsh.50@gmail.com

Hepatitis Monthly:Vol. 7, issue 4; 217-221
Published online:Dec 31, 2007
Article type:Research Article
Received:Nov 25, 2007
Accepted:Jan 28, 2008
How to Cite:Shokouhi S, Rakhshan M, Gachkar L, Khalaj E, Sazgar S. Effects of Hepatitis B Surface and Hepatitis B Core Antigens from Hepatitis B Virus Genotypes B and C on In Vitro Apoptosis. Hepat Mon. 2007;7(4):. doi:

Abstract

Background and Aims: Liver biopsy is the best known technique for evaluation of liver fibrosis. However, alternative diagnostic methods have been investigated to replace this invasive procedure. Our aim was to assess the diagnostic performance of platelet count and biochemical markers for the staging of liver fibrosis in our patients.

Methods: In a descriptive study, records of all consecutive patients who underwent liver biopsy at Loghman Hakim & Taleghani hospitals between March 2000 and March 2004 were retrospectively studied. The clinical and laboratory data were obtained from patients' clinical records. Liver histology samples were reviewed by an expert pathologist. The platelet count, serum albumin levels, and the ratio of serum aspartate aminotransferase (AST) levels to platelet count were used as markers for fibrosis. Cutoff points for some of these markers were established using the ROC curve. 

Results: One hundred thirty patients (94 males & 36 females) were studied. The AST/platelet ratio at the cutoff point 0.39 had a positive predictive value (PPV) of 0.70 and a negative predictive value (NPV) of 0.54 to differentiate patients without liver fibrosis from those with moderate fibrosis. This ratio had a PPV = 0.76 and NPV = 0.70 to differentiate patients without liver fibrosis from those with severe fibrosis when used at a cutoff point of 0.25. The platelet count at the cutoff point of 158500 was used for the distinction of mild from moderate fibrosis. The platelet count at the cutoff point of 151000 and serum albumin at the cutoff point of 3.6 were used for distinction of mild from severe fibrosis. No single marker was found to diagnose different stages of fibrosis. 

Conclusions: The AST/platelet ratio had an appropriate cutoff point to differentiate patients without liver fibrosis from patients with moderate to severe liver fibrosis. The clinical utility of these tests requires further investigation.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2007, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

28
Feb
2014
Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B

Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B

Simin Dokht Shoaei,
Shahnaz Sali,
Mehdi Karamipour,
Esmail Riahi

Shoaei SD, Sali S, Karamipour M, Riahi E. Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B. Hepat Mon. 2014;14(2):e14228. doi: https://doi.org/10.5812/hepatmon.14228

1
Apr
2014
Evaluation of the Relation Between Hepatic Fibrosis and Basic Laboratory Parameters in Patients With Chronic Hepatitis B Fibrosis and Basic Laboratory Parameters

Evaluation of the Relation Between Hepatic Fibrosis and Basic Laboratory Parameters in Patients With Chronic Hepatitis B Fibrosis and Basic Laboratory Parameters

Nazlim Aktug Demir,
Servet Kolgelier,
Serap Ozcimen,
Gokhan Gungor,
Sua Sumer,
Lutfi Saltuk Demir
,et al.

Demir NA, Kolgelier S, Ozcimen S, Gungor G, Sumer S, et al. Evaluation of the Relation Between Hepatic Fibrosis and Basic Laboratory Parameters in Patients With Chronic Hepatitis B Fibrosis and Basic Laboratory Parameters. Hepat Mon. 2014;14(4):e16975. doi: https://doi.org/10.5812/hepatmon.16975

27
Nov
2019
King’s Fibrosis, Fibrosis Index, GPR, and ALBI Score Are Useful Models for Liver Fibrosis in Chronic Hepatitis B Patients Pre- and Post-Treatment

King’s Fibrosis, Fibrosis Index, GPR, and ALBI Score Are Useful Models for Liver Fibrosis in Chronic Hepatitis B Patients Pre- and Post-Treatment

Ayman Alsebaey,
Reda Badr,
Eman Abdelsameea,
Mohamed Omar Amer,
Mohamed Ashraf Eljaky,
Gasser El-Azab
,et al.

Alsebaey A, Badr R, Abdelsameea E, Amer MO, Eljaky MA, et al. King’s Fibrosis, Fibrosis Index, GPR, and ALBI Score Are Useful Models for Liver Fibrosis in Chronic Hepatitis B Patients Pre- and Post-Treatment. Hepat Mon. 2019;19(11):e96081. doi: https://doi.org/10.5812/hepatmon.96081

23
Jul
2017
Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey

Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey

Pinar Korkmaz,
Nese Demirturk,
Ayse Batırel,
Ahmet Cem Yardimci,
Unal Cagir,
Salih Atakan Nemli
,et al.

Korkmaz P, Demirturk N, Batırel A, Cem Yardimci A, Cagir U, et al. Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey. Hepat Mon. 2017;17(12):e60266. doi: https://doi.org/10.5812/hepatmon.60266

23
Mar
2024
Non-invasive Assessment of Liver Damage Degree in Patients with Viral Hepatitis: Is It Feasible and Acceptable?

Non-invasive Assessment of Liver Damage Degree in Patients with Viral Hepatitis: Is It Feasible and Acceptable?

Vladimir Vračarić,
Božidar Dejanović,
Nebojsa Janjić,
Milica Zirojević,
Željka Savić,
Olgica Latinović Bosnjak
,et al.

Vračarić V, Dejanović B, Janjić N, Zirojević M, Savić Ž, et al. Non-invasive Assessment of Liver Damage Degree in Patients with Viral Hepatitis: Is It Feasible and Acceptable?. Hepat Mon. 2024;24(1):e144504. doi: https://doi.org/10.5812/hepatmon-144504

More by these authors

Shervin ShokouhiPubMedScholar
Mohammad RakhshanPubMedScholar
Latif GachkarPubMedScholar
Elham KhalajPubMedScholar
Sasan SazgarPubMedScholar
Share
Cited by
Metrics